Smiths Detection Opens New UK Biolab
November 22, 2022 | Smiths DetectionEstimated reading time: 1 minute
Smiths Detection, a global leader in the development of threat detection and security screening equipment, opened a biolab at its centre of excellence in Hemel Hempstead, UK. The new lab will complement the research capabilities of Baltimore, Maryland site, in developing next generation biological threat detection capabilities primarily for its BioFlash Biological Identifier.
Smiths Detection’s BioFlash is a desktop biothreat detection system that uses CANARY® technology (a cell-based biosensor) in combination with proprietary aerosol-collection techniques to rapidly identify biothreat agents from an air sample. Already the BioFlash is capable of detecting biothreats such as anthrax, ricin, botulinum toxin, black plague, tularemia, smallpox, and SARS-CoV-2. The Hemel Hempstead lab will work alongside colleagues in the US to develop new detection capabilities for known threats and be able to better respond to emergence of yet known threats.
Producing BioFlash’s BioDiscs out of Hemel Hempstead allows Smiths Detection to provide an even better service to its customers across Europe and nearby regions. The BioFlash received a CE marking in October opening the way for the product to be sold in the EU.
Smiths Detection’s Vice President of Technology, Matt Clark, said of the opening, “The new Biolab in Hemel Hempstead is a milestone for Smiths Detection and demonstrates our commitment to responding quickly to new and emerging threats and to supporting our customers in the region.”
Recently, Smiths Detection BioFlash was used at the Birmingham 2022 Commonwealth Games to support test high-security areas for the presence of SAR-CoV-2, with the UK biolab manufacturing and supplying the necessary BioDiscs throughout the Games.
Suggested Items
Devan Iyer, Industry Leader on Chips Packaging Technology, Joins IPC
03/18/2024 | IPCDevan Iyer, Ph.D., one of the semiconductor industry’s leading technology experts, has joined IPC as its chief strategist for advanced packaging. In this newly created role, Dr. Iyer leads IPC's work with leading electronics companies and governments to identify and deliver news solutions to IPC members and the industry.
Expanded Semiconductor Assembly and Test Facility Database Tracks OSAT and Integrated Device Manufacturers in 670 Facilities
03/18/2024 | SEMIThe new edition of the Worldwide Assembly & Test Facility Database expands coverage to 670 facilities, 33% more than the previous release, including 500 outsourced semiconductor assembly and test (OSAT) service providers and 170 integrated device manufacturer (IDM) facilities, SEMI and TechSearch International announced.
Northrop Grumman and Diehl Defence to Collaborate on Integrated Air and Missile Defense Capabilities
03/12/2024 | Northrop GrummanNorthrop Grumman Corporation and Diehl Defence GmbH & Co. KG signed a Memorandum of Understanding (MOU) formalizing their commitment to work together to support innovative layered air and missile defense capabilities for Germany.
GEN3 to Demo SIR Testing, Stencil Cleaning & More with Horizon Sales at IPC APEX 2024
03/07/2024 | Gen3Gen3, global leader in SIR, CAF, Solderability, Ionic Contamination & process optimisation equipment, to announce its participation in the 2024 IPC APEX EXPO, scheduled to take place April 9-11, 2024 at the Anaheim Convention Center in California. At booth 3934, GEN3 will be exhibiting alongside Horizon Sales, presenting a lineup of advanced technologies aimed at enhancing the efficiency and reliability of circuit assembly processes.
RTX's Raytheon Completes First Flight Test for New AMRAAM-ER Variant
03/05/2024 | RTXRaytheon, an RTX business, and Kongsberg Defence & Aerospace, with support from the Norwegian Ministry of Defense (MoD) and Armed Forces, successfully completed a flight test of an updated AMRAAM®-Extended Range missile variant from a National Advanced Surface-to-Air Missile System (NASAMS).